Evidence map›Paper›PMID 42397946›Full record

ArticleJournal of medical Internet research2026

Integrating Participatory Social Innovation Into Requirements Engineering for AI Health Care Solutions: Case Study.

Carina Dantas, Miriam Cabrita, Maciej Bobowicz, Harm Op den Akker, Xavier Rafael-Palou, Tuukka Hakkarainen, Ira Haavisto, Fredrik Strand, Luis Marti-Bonmati, Eugen Divjak and 9 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Carina DantasSHINE 2Europe (Portugal), Rua Câmara Pestana Lote 3 - 1ºD/F, Coimbra, Coimbra, Portugal, +351936498277.ORCID http://orcid.org/0000-0002-9887-7622
Miriam Cabrita *SHINE 2Europe (Portugal), Rua Câmara Pestana Lote 3 - 1ºD/F, Coimbra, Coimbra, Portugal, +351936498277.ORCID http://orcid.org/0000-0001-6757-9406
Maciej Bobowicz *2nd Division of Radiology, Medical University of Gdansk, Gdansk, Poland.ORCID http://orcid.org/0000-0002-3608-1960
Harm Op den AkkerSHINE 2Europe (Portugal), Rua Câmara Pestana Lote 3 - 1ºD/F, Coimbra, Coimbra, Portugal, +351936498277.ORCID http://orcid.org/0000-0001-6312-6063
Xavier Rafael-PalouQuantitative Imaging Biomarkers in Medicine, Quibim SL, Valencia, Spain.ORCID http://orcid.org/0000-0002-4489-4806
Tuukka HakkarainenResearch & Innovation, Nordic Healthcare Group, Espoo, Finland.ORCID http://orcid.org/0000-0002-9050-5349
Ira HaavistoResearch & Innovation, Nordic Healthcare Group, Espoo, Finland.ORCID http://orcid.org/0000-0002-6948-845X
Fredrik StrandDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.ORCID http://orcid.org/0000-0003-3910-7086
Luis Marti-BonmatiBiomedical Imaging Research Group (GIBI230), La Fe Health Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0002-8234-010X
Eugen DivjakDepartment for Diagnostic and Interventional Radiology, University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia.ORCID http://orcid.org/0000-0002-9709-5450
Gordana IvanacDepartment for Diagnostic and Interventional Radiology, University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia.ORCID http://orcid.org/0000-0001-8419-1534
Smriti JoshiDepartament de Matemàtiques i Informàtica, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8480-023X
Richard OsualaDepartament de Matemàtiques i Informàtica, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-1835-8564
Stefanie CharalambousR&D department (Health sector), Maggioli S.p.A - Greek branch, Marousi, Greece.ORCID http://orcid.org/0009-0002-9826-3302
Apostolia TsirikoglouDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.ORCID http://orcid.org/0000-0003-0298-937X
Gloria RibasBiomedical Imaging Research Group (GIBI230), La Fe Health Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0001-6883-4130
Oliver DíazDepartament de Matemàtiques i Informàtica, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6789-5177
Ana Sofia CarvalhoSchool of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-1132-8880
Elísio CostaRISE-Health, Competences Centre on Active and Healthy Ageing (Porto4Ageing), Faculty of Pharmacy of University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-1158-1480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The successful design and implementation of artificial intelligence (AI)-driven solutions in health care requires early and continuous multidisciplinary and multiprofessional collaboration. However, diverse disciplinary educational backgrounds, varying languages, and cultural or geographic differences can lead to misunderstandings. To bridge this gap, a structured approach to AI requirements specification can facilitate a shared terminology and a deep mutual understanding among stakeholders, serving both as a guide for technological development and as a means of defining clear pathways for clinical implementation. While technical requirements are well-established in traditional technology development domains, this structured approach remains relatively underused within clinical and social science contexts. Consequently, valuable insights derived from participatory and stakeholder-driven approaches are often overlooked, limiting the relevance and trustworthiness of AI systems in health care settings. Objective: This study presents a methodology for requirements gathering, specification, mapping, and verification, specifically engineered for the complex, multistakeholder environment of clinically applied AI. The methodology was implemented within the specific case of an international multidisciplinary project evaluating an AI-based prediction tool for neoadjuvant chemotherapy treatment response for breast cancer and forming a part of the developed AI validation framework. Methods: The process for AI requirements gathering, specification, and monitoring included 3 iterative rounds of discussion, engaging nearly 150 social, clinical, technical, ethical, and regulatory experts and patients across Europe, South America, North Africa, and Eurasia. It combines established requirements engineering methods (including the MoSCoW [Must have, Should have, Could have, Will not have] framework) with social innovation techniques to ensure inclusivity and contextual relevance. Results: A key finding is the successful development of a structured framework integrating participatory social innovation with formal requirements engineering in an international AI health care setting, through a traceable multisource workflow including clinical, ethical, and regulatory aspects. It is supplemented with an extensive list of 184 actionable consensus-based requirements, categorized by stakeholder group, providing valuable insights for AI researchers in the oncology field with the potential to be transferable to other digital health domains. The requirements align with the fairness, universality, traceability, usability, robustness, and explainability in the AI (FUTURE-AI) framework, ensuring the tool is trustworthy and comprehensive from a multistakeholder perspective, and ensuring comprehensive consideration of all elements of FUTURE-AI. Conclusions: The proposed methodology represents a significant advancement for requirements engineering in digital health by extending traditional technical processes to systematically incorporate nontechnical requirements from diverse global stakeholders. This unified approach is essential for ensuring AI solutions are not only technically robust but also clinically relevant, legally compliant, and socially acceptable.

Indexed as

Artificial IntelligenceDelivery of Health CareSocial ChangeBreast NeoplasmsHumansartificial intelligenceethicsmultistakeholder engagamentrequirements engineeringsocial innovation

Identifiers

PMID42397946
PMCPMC13331246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.